Drug-repositioning screening identified fludarabine and risedronic acid as potential therapeutic compounds for malignant pleural mesotheliomaIrene Dell’Anno, Stefano Landi|Investigational New Drugs|2020Cited by 12
Thonzonium bromide inhibits progression of malignant pleural mesothelioma through regulation of ERK1/2 and p38 pathways and mitochondrial uncouplingIrene Dell’Anno, Stefano Landi|Cancer Cell International|2024Cited by 1